Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection.
Feria MG, Chang C, Ticona E, Moussa A, Zhang B, Ballena I, Azañero R, Ticona C, De Cecco CN, Fichtenbaum CJ, O'Donnell RE, La Rosa A, Sanchez J, Andorf S, Atehortua L, Katz JD, Chougnet CA, Deepe GS Jr, Huaman MA. Feria MG, et al. Among authors: ticona c. Open Forum Infect Dis. 2022 Nov 19;9(12):ofac629. doi: 10.1093/ofid/ofac629. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36570965 Free PMC article.
Latent tuberculosis infection is associated with increased unstimulated levels of interferon-gamma in Lima, Peru.
Huaman MA, Henson D, Rondan PL, Ticona E, Miranda G, Kryscio RJ, Mugruza R, Aranda E, Ticona C, Abarca S, Heredia P, Aguirre A, Sterling TR, Garvy BA, Fichtenbaum CJ. Huaman MA, et al. Among authors: ticona c. PLoS One. 2018 Sep 13;13(9):e0202191. doi: 10.1371/journal.pone.0202191. eCollection 2018. PLoS One. 2018. PMID: 30212453 Free PMC article. Clinical Trial.
Latent Tuberculosis Infection and Subclinical Coronary Atherosclerosis in Peru and Uganda.
Huaman MA, De Cecco CN, Bittencourt MS, Ticona E, Kityo C, Ballena I, Nalukwago S, Nazzinda R, Ticona C, Azañero R, Zhang B, Farquhar C, Hawn TR, Sterling TR, Fichtenbaum CJ, Longenecker CT. Huaman MA, et al. Among authors: ticona c. Clin Infect Dis. 2021 Nov 2;73(9):e3384-e3390. doi: 10.1093/cid/ciaa1934. Clin Infect Dis. 2021. PMID: 33388766 Free PMC article.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD; endTB Clinical Trial Team. Guglielmetti L, et al. N Engl J Med. 2025 Jan 30;392(5):468-482. doi: 10.1056/NEJMoa2400327. N Engl J Med. 2025. PMID: 39879593 Free PMC article. Clinical Trial.